01—History
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $2.33
1 older move runs past ±150% (largest +206.9%); point at, tap or drag across the bars to read one.
02—Ledger
03—Questions
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is ALNYLAM PHARMACEUTICALS, INC.'s current eps (diluted)?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual eps (diluted) for 2025 was $2.33, a 206.88% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. eps (diluted) for the quarter ending September 30, 2025 was $1.84.
What was ALNYLAM PHARMACEUTICALS, INC.'s eps (diluted) in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual eps (diluted) for 2024 was $-2.18, a 38.07% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s eps (diluted) in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual eps (diluted) for 2023 was $-3.52, a 62.15% increase from 2022.
- Company
- ALNYLAM PHARMACEUTICALS, INC.
- Ticker
- ALNY
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations